Your Source for Blood Cancer Treatment in New Jersey

Hematologic malignancies such as lymphoma, leukemia, myeloma, and myelodysplasia affect bone marrow, lymph nodes, blood cells, and the lymphatic system. We employ a multidisciplinary approach that provides the most promising therapies, techniques, and technologies to treat patients with blood cancers.

Because world-class treatment of these cancers requires a collaborative approach across many specialties, our cancer care teams thoroughly review cases regularly to evaluate treatment options and therapies for each patient. This ensures that every individual receives the highest level of clinical expertise and all aspects of care are coordinated on an individualized basis.

Learn more about the types of blood cancers we treat, as well as patient stories and details on clinical trials. We are pleased to offer a wealth of information that can equip you to obtain effective cancer care from a team of forward-thinking oncologists.

Through our partnership with Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, we provide patients access to the full spectrum of therapeutic procedures and advanced treatment options such as blood and marrow transplantation, the latest clinical trials, immunotherapy and other cellular therapies. Rutgers Cancer Institute is one of the first programs in the state to offer CAR-T cell therapy. CAR-T cell therapy is currently only offered at centers that perform stem cell transplants, have specially trained clinicians and healthcare personnel, and are FACT (Foundation for the Accreditation of Cellular Therapy) certified.